Home/Filings/4/0001213900-25-048304
4//SEC Filing

Weisblum Eric 4

Accession 0001213900-25-048304

CIK 0001514183other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 4:30 PM ET

Size

5.3 KB

Accession

0001213900-25-048304

Insider Transaction Report

Form 4
Period: 2025-05-27
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
  • Purchase

    Common Stock

    2025-05-27$0.43/sh+10,000$4,329197,932 total
Footnotes (1)
  • [F1]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $0.42 to $0.45, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Silo Pharma, Inc.

CIK 0001514183

Entity typeother

Related Parties

1
  • filerCIK 0001569077

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:30 PM ET
Size
5.3 KB